JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis
ABSTRACT A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis
MY Choi, S Kato, HY Wang, JH Lin… - Cancer biology & …, 2018 - pubmed.ncbi.nlm.nih.gov
A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans polyostotic
sclerosing histiocytosis) had next-generation sequencing (NGS) performed as part of his …
sclerosing histiocytosis) had next-generation sequencing (NGS) performed as part of his …
[HTML][HTML] JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis
MY Choi, S Kato, HY Wang, JH Lin… - Cancer Biology & …, 2018 - ncbi.nlm.nih.gov
ABSTRACT A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis.
MY Choi, S Kato, HY Wang, JH Lin… - Cancer Biology & …, 2018 - europepmc.org
ABSTRACT A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis
MY Choi, S Kato, HY Wang, JH Lin… - Cancer Biology & …, 2018 - escholarship.org
A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans polyostotic
sclerosing histiocytosis) had next-generation sequencing (NGS) performed as part of his …
sclerosing histiocytosis) had next-generation sequencing (NGS) performed as part of his …
JAK2 V617F mutation in plasma cell-free DNA preceding clinically overt myelofibrosis: Implications for early diagnosis.
MY Choi, S Kato, HY Wang, JH Lin… - Cancer Biology & …, 2018 - europepmc.org
ABSTRACT A 52 year-old man with Erdheim-Chester Disease (ECD)(a non-Langerhans
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …
polyostotic sclerosing histiocytosis) had next-generation sequencing (NGS) performed as …